Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Victory Square Technologies Inc. C.VST

Alternate Symbol(s):  VSQTF

Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed for fast-track growth. VST's sweet spot is cutting-edge tech that's shaping the 4th Industrial Revolution. Our corporate portfolio consists of 25+ global companies using AI, VR/AR, and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.


CSE:VST - Post by User

Post by Warzonaon Jul 28, 2021 11:45pm
193 Views
Post# 33619380

List of $VST NRs regarding their Covid-19 Pump

List of $VST NRs regarding their Covid-19 PumpThis company is lied to its shareholders and used many fake NRs about their Covid-19 test kits and victory square health. All of sudden everything disapeared about their covif test kits. It was a clear scam and CSE should follow up and ask the company where the fuk your sales, if not, they should charge VST with fraud

Victory Square Health makes acquisition to accelerate the development and commercialization of a Covid-19 15-minute antibody-based test

JUNE 10, 2020

 

Victory Square Technologies Portfolio Company Gets FDA Permission to Manufacture and Market Safetest Covid-19 Antibody Test

AUGUST 25, 2020

 

Victory Square Technologies Portfolio Company is the first to be approved by the So Paulo State Government COVID-19 Innovation Programme

AUGUST 27, 2020

 

Victory Square Health Increases Monthly Production of Rapid Covid-19 Test Kits to Meet Increased Demand with New Manufacturing Agreement with Gold Analisa Diagnostica Ltda

SEPTEMBER 2, 2020

 

Victory Square Technologies Portfolio Company Receives Brazilian ANVISA Approval for Sale & Use of Safetest Covid-19 Antibody Test for the Country of Brazil

SEPTEMBER 8, 2020

 

Victory Square Health Receives Approval for Sale and Use of Safetest Covid-19 Antibody Test for the European Union

SEPTEMBER 14, 2020

 

Victory Square Health Provides a Progress Update on its Covid-19 Test

SEPTEMBER 21, 2020

 

Victory Square Health Announces Update To Previous News Release

SEPTEMBER 23, 2020

 

Victory Square Technologies Portfolio Company Acquires Brazilian Manufacturing & Laboratory Facility to Increase Production of its Covid-19 Testing Products by an additional 4,000,000 Units in Brazil

SEPTEMBER 25, 2020

 

Victory Square Technologies Portfolio Company receives an order of Safetest Covid-19 Testing Kits from North America’s TM Safety Supplies Company

SEPTEMBER 28, 2020

 

Victory Square Technologies Portfolio Company Enters into a Distribution & Testing Agreement with the Canadian Police Association to Provide Safetest Covid-19 Testing Kits & on-Site Testing Services to over 60,000 Members in Canada

SEPTEMBER 30, 2020

 

Victory Square Health Applies to Health Canada for Approval of its Safetest Covid-19™ Rapid Test for Sale & Distribution in Canada

OCTOBER 6, 2020

 

 

Technologies Portfolio Company Receives FDA Permission Under EUA for Sale & Distribution of 15 Minute 96.6% Sensitivity Safetest Covid-19 Rapid Test for the United States

OCTOBER 13, 2020

 

Victory Square Technologies Portfolio Company Establishes Distribution Network in Hong Kong, Philippines, Malaysia, Thailand, & Singapore for Safetest Covid-19 Testing Kits

OCTOBER 15, 2020

 

Victory Square Technologies Portfolio Company Receives Approval for Sale & Distribution of 15 Minute 96.6% Sensitivity Safetest Covid-19 Rapid Test for the European Union

OCTOBER 19, 2020

 

Victory Square Technologies Portfolio Company Enters Into Sales & Distribution Agreement for Safetest 15 Minute Covid-19 Rapid Test for Greece, Cyprus, Romania, Bulgaria, Northern Macedonia, & Serbia

OCTOBER 28, 2020

 

Victory Square Technologies Portfolio Company Enters into Sales & Distribution Agreement for Safetest 15 Minute Covid-19 Rapid Test for North America with ProNorth Medical Corp.

NOVEMBER 12, 2020

 

Victory Square Technologies Portfolio Company’s Leishmaniasis Rapid Test Receives Brazilian MAPA Approval for Sale & Use for the Country of Brazil and Enters into a Sales & Distribution Contract with Ecodiagnostica of Brazil

NOVEMBER 13, 2020

 

Victory Square Technologies Portfolio Company Enters into a Key Business Development & Sales Agreement for its Safetest Covid-19 Rapid and other Tests with MOLKOM Pharmaceuticals

NOVEMBER 17, 2020

 

Victory Square Technologies Enters Into White Label Manufacturing, Sales & Distribution Agreements For Covid-19 Rapid Antibody and Antigen Tests for Europe & the United States

DECEMBER 7, 2020

 

Victory Square Technologies Portfolio Company Enters Into Sales & Distribution Contract with Brazilian Company for an Initial Order of 3.7 Million Covid-19 Rapid Tests for Brazil

DECEMBER 14, 2020

 

Victory Square Technologies Receives Approval for Sale & Distribution of VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test for Entire European Union

DECEMBER 21, 2020

 

Victory Square Technologies Portfolio Company Receives Brazilian ANVISA Approval for Sale, Distribution & Use of Safetest 15 Minute Covid-19 Rapid Test for Brazil

JANUARY 11, 2021

 

<< Previous
Bullboard Posts
Next >>